The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
An earthquake measuring 5.6 hits central Turkey. No immediate reports of casualties or damage
WNBA will pay for flights for playoffs and back
NFL's first medical summit brought teams together to collaborate on improving player safety
Former New Mexico football player convicted of robbing a postal carrier
University of Oregon football player, 19, is arrested for fatal hit and run after 46
Boeing pushes back on whistleblower's allegations and details how airframes are put together
Shanghai airports see surge in inbound foreign travelers in Q1
Former New Mexico football player convicted of robbing a postal carrier
The Titans go into the NFL draft flexible at No. 7 with lots of needs to fill
Busch Gardens Tampa Bay: Endangered Bornean orangutan born in Florida
Horoscope today: Daily guide to what the stars have in store for YOU
4 family members plead not guilty in abduction and abuse of a malnourished Iowa teen